Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older who are able to give informed consent to participate
- People who have an open wound or ulcer, particularly one with tunneling (a channel under the skin) or undermining (where the skin separates from the tissue beneath)
- If more than one wound is present, one wound will be selected for treatment, and any other wounds must be at least 2 cm away from the selected wound
- The wound must have been cleaned out (debrided) with the aim of healing, even if some infection is still present
- Any previous infections in or around the wound must have been appropriately treated and brought under control
- People who are willing and able to follow offloading (reducing pressure on the wound) and/or compression requirements as directed
- People who have a stable home environment that supports consistent wound care
- The selected wound must have a clean base with no dead tissue or debris at the time of treatment
- People who agree to have photos of their wound taken for the study
Who may not be able to join:
- People with an active, untreated bone infection (osteomyelitis)
- People whose wound involves cancer or blood vessel inflammation (vasculitis)
- People currently receiving chemotherapy
- People currently on dialysis (kidney filtering treatment)
- People who have used experimental drugs or treatments within the 30 days before screening
- People with conditions that would make it difficult to follow the study requirements, or a known history of not following medical instructions
- People with a known sensitivity or allergy to pig-derived (porcine) materials
- People with third-degree burns
- People whose wound shows worsening reduced blood flow or tissue death (gangrene) at the time of screening
- People who have previously had radiation treatment at the wound site
- People whose wound has exposed metal hardware, implants, or fixation devices in it
- People currently receiving palliative or comfort care only
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Robert J. Snyder, DPM, Barry University
Phone: 954-721-4806
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percent Area Reduction (PAR) and Granulation Tissue Formation at 4 and 12 Weeks
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.